Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC
- PMID: 25037524
- PMCID: PMC4778557
- DOI: 10.1016/j.schres.2014.04.033
Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC
Abstract
Cannabis use disorder (CUD) occurs in up to 42% of patients with schizophrenia and substantially worsens disease progression. The basis of CUD in schizophrenia is unclear and available treatments are rarely successful at limiting cannabis use. We have proposed that a dysregulated brain reward circuit (BRC) may underpin cannabis use in these patients. In the present pilot study, we used whole-brain seed-to-voxel resting state functional connectivity (rs-fc) to examine the BRC of patients with schizophrenia and CUD, and to explore the effects of smoked cannabis and orally administered delta-9-tetrahydrocannabinol (THC) on the BRC. 12 patients with schizophrenia and CUD and 12 control subjects each completed two fMRI resting scans, with patients administered either a 3.6% THC cannabis cigarette (n=6) or a 15 mg THC capsule (n=6) prior to their second scan. Results revealed significantly reduced connectivity at baseline in patients relative to controls, with most pronounced hypoconnectivity found between the nucleus accumbens and prefrontal cortical BRC regions (i.e., anterior prefrontal cortex, orbitofrontal cortex, and anterior cingulate cortex). Both cannabis and THC administration increased connectivity between these regions, in direct correlation with increases in plasma THC levels. This study is the first to investigate interregional connectivity of the BRC and the effects of cannabis and THC on this circuit in patients with schizophrenia and CUD. The findings from this pilot study support the use of rs-fc as a means of measuring the integrity of the BRC and the effects of pharmacologic agents acting on this circuit in patients with schizophrenia and CUD.
Keywords: Brain reward circuitry; Cannabis use disorder; Nucleus accumbens; Resting state functional connectivity; Schizophrenia; fMRI.
Copyright © 2014. Published by Elsevier B.V.
Figures
Comment in
-
Cortico-accumbens circuitry in schizophrenia: merely a "reward system"?Schizophr Res. 2014 Dec;160(1-3):233-4. doi: 10.1016/j.schres.2014.10.009. Epub 2014 Oct 27. Schizophr Res. 2014. PMID: 25458864 No abstract available.
Similar articles
-
Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.Schizophr Res. 2018 Apr;194:70-77. doi: 10.1016/j.schres.2017.07.029. Epub 2017 Aug 18. Schizophr Res. 2018. PMID: 28823723 Free PMC article.
-
Effect of Δ9-Tetrahydrocannabinol on frontostriatal resting state functional connectivity and subjective euphoric response in healthy young adults.Drug Alcohol Depend. 2021 Apr 1;221:108565. doi: 10.1016/j.drugalcdep.2021.108565. Epub 2021 Feb 3. Drug Alcohol Depend. 2021. PMID: 33592558 Free PMC article. Clinical Trial.
-
Cannabinoid modulation of functional connectivity within regions processing attentional salience.Neuropsychopharmacology. 2015 May;40(6):1343-52. doi: 10.1038/npp.2014.258. Epub 2014 Sep 23. Neuropsychopharmacology. 2015. PMID: 25249057 Free PMC article.
-
The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users.Biol Psychiatry. 2016 Apr 1;79(7):e17-31. doi: 10.1016/j.biopsych.2015.11.013. Epub 2015 Dec 4. Biol Psychiatry. 2016. PMID: 26858212 Review.
-
Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:53-69. doi: 10.1016/j.pnpbp.2013.11.017. Epub 2013 Dec 29. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24380726 Review.
Cited by
-
Spontaneous Brain Activity Alterations in First-Episode Psychosis: A Meta-analysis of Functional Magnetic Resonance Imaging Studies.Schizophr Bull. 2023 Nov 29;49(6):1494-1507. doi: 10.1093/schbul/sbad044. Schizophr Bull. 2023. PMID: 38029279
-
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.Schizophr Res. 2023 Oct;260:191-197. doi: 10.1016/j.schres.2023.08.023. Epub 2023 Sep 11. Schizophr Res. 2023. PMID: 37683509 Free PMC article.
-
Smoked Cannabis Effects in Cannabis Users at Clinical High-Risk for Psychosis: A Further Investigation of Cognition and Reward.Cannabis. 2022 Feb 22;5(1):18-29. doi: 10.26828/cannabis/2022.01.003. eCollection 2022. Cannabis. 2022. PMID: 37287664 Free PMC article.
-
Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance.Transl Psychiatry. 2022 Sep 23;12(1):403. doi: 10.1038/s41398-022-02186-4. Transl Psychiatry. 2022. PMID: 36151087 Free PMC article.
-
Maternal immune activation and adolescent alcohol exposure increase alcohol drinking and disrupt cortical-striatal-hippocampal oscillations in adult offspring.Transl Psychiatry. 2022 Jul 20;12(1):288. doi: 10.1038/s41398-022-02065-y. Transl Psychiatry. 2022. PMID: 35859084 Free PMC article.
References
-
- Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of general psychiatry. 2009;66(4):442–451. - PubMed
-
- Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999;94(9):1311–1322. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
